A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Clinical trial NCT01617447 · COMPLETED

Trial details

NCT number: NCT01617447
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Autistic Disorder

Start date: 2012-07-01
Primary completion: 2015-06-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.